Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Models of Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy.

NCT01799421 is registered in ClinicalTrials.gov with Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología as lead sponsor.

NCT NCT01799421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01799421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Models of Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy.
Lead sponsor
Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2015
Enrollment
420 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

non-hematologic cancer